A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
Clinical trial NCT00097487 · COMPLETED
Trial details
- NCT number
- NCT00097487
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2000-11-30
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.